Optimizing Cardiovascular Health: Advancements in LDL Cholesterol Management through Intensive and Early Treatment Strategies - Episode 10
Diabetes, GLP-1, and Lipid Reduction
Michael Blaha, MD, highlights the potential of GLP-1 agonists in lowering LDL cholesterol, triglycerides, and body weight in patients with diabetes, presenting them as an additional option for reducing cardiovascular risk in this patient population.
